BIO-key International (BKYI) Proxy filing summary

Executive summary

• At the reconvened 2026 Annual Meeting on October 2, stockholders approved Proposals 1–3; the meeting was adjourned to allow more time to vote on Proposal 4.

• The meeting is scheduled to reconvene October 30, 2026, at 10:00 a.m. local time, at 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ.

Voting matters and shareholder proposals

• Proposal 4 seeks approval under Nasdaq Listing Rule 5635(d) to issue up to 1,236,668 common shares upon exercise of warrants from the August 10, 2026 warrant inducement transaction; its poll remains open.

• Polls for Proposals 1–3 are closed. Eligible stockholders who have not voted on Proposal 4 are encouraged to vote in favor promptly.

• Stockholders who have not voted on Proposal 4 must submit a new proxy using the revised card or Internet or telephone voting; those who already voted and do not wish to change their vote need take no further action.

• The record date remains July 15, 2026.